A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

NCT06766552 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis (AS)
Psoriatic Arthritis (PsA)
Nr-axSpA
Polymyalgia Rheumatica (PMR)
Takayasu Arteritis (TAK)
Giant Cell Arteritis (GCA)
Behcet's Disease
Enthesitis-related Arthritis

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University